GBA Variants and Parkinson Disease: Mechanisms and Treatments
L Smith, AHV Schapira - Cells, 2022 - mdpi.com
The GBA gene encodes for the lysosomal enzyme glucocerebrosidase (GCase), which
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
Non-motor features of Parkinson disease
AHV Schapira, KR Chaudhuri, P Jenner - Nature Reviews …, 2017 - nature.com
Many of the motor symptoms of Parkinson disease (PD) can be preceded, sometimes for
several years, by non-motor symptoms that include hyposmia, sleep disorders, depression …
several years, by non-motor symptoms that include hyposmia, sleep disorders, depression …
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
For the last two decades, pathogenic concepts in Parkinson disease (PD) have revolved
around the toxicity and spread of α-synuclein. Thus, α-synuclein would follow caudo-rostral …
around the toxicity and spread of α-synuclein. Thus, α-synuclein would follow caudo-rostral …
[HTML][HTML] Clinical and imaging evidence of brain-first and body-first Parkinson's disease
J Horsager, K Knudsen, M Sommerauer - Neurobiology of disease, 2022 - Elsevier
Braak's hypothesis has been extremely influential over the last two decades. However,
neuropathological and clinical evidence suggest that the model does not conform to all …
neuropathological and clinical evidence suggest that the model does not conform to all …
GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches
GM Riboldi, AB Di Fonzo - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is the second most common degenerative disorder. Although the
disease was described more than 200 years ago, its pathogenetic mechanisms have not yet …
disease was described more than 200 years ago, its pathogenetic mechanisms have not yet …
Visual dysfunction in Parkinson's disease
Patients with Parkinson's disease have a number of specific visual disturbances. These
include changes in colour vision and contrast sensitivity and difficulties with complex visual …
include changes in colour vision and contrast sensitivity and difficulties with complex visual …
Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment
S Prange, H Klinger, C Laurencin, T Danaila… - Drugs & Aging, 2022 - Springer
Depression is one of the most frequent and burdensome non-motor symptoms in
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …
Olfactory dysfunction in neurodegenerative diseases
C Marin, D Vilas, C Langdon, I Alobid… - Current allergy and …, 2018 - Springer
Abstract Purpose of Review The sense of smell is today one of the focuses of interest in
aging and neurodegenerative disease research. In several neurodegenerative diseases …
aging and neurodegenerative disease research. In several neurodegenerative diseases …
Prodromal Parkinson's disease: the decade past, the decade to come
RB Postuma, D Berg - Movement disorders, 2019 - Wiley Online Library
The past decade has seen a dramatic expansion of the field of prodromal PD. Ten years
ago, there were only six known prodromal markers of disease, none of which had more than …
ago, there were only six known prodromal markers of disease, none of which had more than …
The concept of prodromal Parkinson's disease
P Mahlknecht, K Seppi… - Journal of Parkinson's …, 2015 - content.iospress.com
Parkinson's disease (PD) is currently clinically defined by a set of cardinal motor features
centred on the presence of bradykinesia and at least one additional motor symptom out of …
centred on the presence of bradykinesia and at least one additional motor symptom out of …